» Articles » PMID: 23408950

'The Words Will Pass with the Blowing Wind': Staff and Parent Views of the Deferred Consent Process, with Prior Assent, Used in an Emergency Fluids Trial in Two African Hospitals

Overview
Journal PLoS One
Date 2013 Feb 15
PMID 23408950
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To document and explore the views and experiences of key stakeholders regarding the consent procedures of an emergency research clinical trial examining immediate fluid resuscitation strategies, and to discuss the implications for similar trials in future.

Methods: A social science sub-study of the FEAST (Fluid Expansion As Supportive Therapy) trial. Interviews were held with trial team members (n = 30), health workers (n = 15) and parents (n = 51) from two purposively selected hospitals in Soroti, Uganda, and Kilifi, Kenya.

Findings: Overall, deferred consent with prior assent was seen by staff and parents as having the potential to protect the interests of both patients and researchers, and to avoid delays in starting treatment. An important challenge is that the validity of verbal assent is undermined when inadequate initial information is poorly understood. This concern needs to be balanced against the possibility that full prior consent on admission potentially causes harm through introducing delays. Full prior consent also potentially imposes worries on parents that clinicians are uncertain about how to proceed and that clinicians want to absolve themselves of any responsibility for the child's outcome (some parents' interpretation of the need for signed consent). Voluntariness is clearly compromised for both verbal assent and full prior consent in a context of such vulnerability and stress. Further challenges in obtaining verbal assent were: what to do in the absence of the household decision-maker (often the father); and how medical staff handle parents not giving a clear agreement or refusal.

Conclusion: While the challenges identified are faced in all research in low-income settings, they are magnified for emergency trials by the urgency of decision making and treatment needs. Consent options will need to be tailored to particular studies and settings, and might best be informed by consultation with staff members and community representatives using a deliberative approach.

Citing Articles

Impact of early continuous positive airway pressure in the delivery room (DR-CPAP) on neonates < 1500 g in a low-resource setting: a protocol for a pilot feasibility and acceptability randomized controlled trial.

Burgoine K, Ssenkusu J, Nakiyemba A, Okello F, Napyo A, Hagmann C Pilot Feasibility Stud. 2024; 10(1):126.

PMID: 39367449 PMC: 11451038. DOI: 10.1186/s40814-024-01552-x.


A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial).

Maitland K, Obonyo N, Hamaluba M, Ogoda E, Mogaka C, Williams T Wellcome Open Res. 2024; 9:281.

PMID: 39184127 PMC: 11342035. DOI: 10.12688/wellcomeopenres.21403.1.


Practical approaches for supporting informed consent in neonatal clinical trials.

Wootton S, Rysavy M, Davis P, Thio M, Romero-Lopez M, Holzapfel L Acta Paediatr. 2024; 113(5):923-930.

PMID: 38389165 PMC: 11006570. DOI: 10.1111/apa.17165.


Questioning approaches to consent in time critical obstetric trials: findings from a mixed-methods study.

Deja E, Weeks A, Van Netten C, Gamble C, Meher S, Gyte G BMJ Open. 2024; 14(2):e081874.

PMID: 38341214 PMC: 10862288. DOI: 10.1136/bmjopen-2023-081874.


Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.

Deja E, Donohue C, Semple M, Woolfall K BMJ Open. 2024; 14(1):e077023.

PMID: 38167280 PMC: 10773389. DOI: 10.1136/bmjopen-2023-077023.


References
1.
Molyneux C, Peshu N, Marsh K . Trust and informed consent: insights from community members on the Kenyan coast. Soc Sci Med. 2005; 61(7):1463-73. DOI: 10.1016/j.socscimed.2004.11.073. View

2.
Maitland K, Kiguli S, Opoka R, Engoru C, Olupot-Olupot P, Akech S . Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364(26):2483-95. DOI: 10.1056/NEJMoa1101549. View

3.
Luce J . Is the concept of informed consent applicable to clinical research involving critically ill patients?. Crit Care Med. 2003; 31(3 Suppl):S153-60. DOI: 10.1097/01.CCM.0000054901.80339.01. View

4.
Jansen T, Bakker J, Kompanje E . Inability to obtain deferred consent due to early death in emergency research: effect on validity of clinical trial results. Intensive Care Med. 2010; 36(11):1962-5. PMC: 2952110. DOI: 10.1007/s00134-010-1988-0. View

5.
Maitland K, Molyneux S, Boga M, Kiguli S, Lang T . Use of deferred consent for severely ill children in a multi-centre phase III trial. Trials. 2011; 12:90. PMC: 3077324. DOI: 10.1186/1745-6215-12-90. View